BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23728753)

  • 1. Is there an increase in the incidence of uterine carcinosarcoma in north-east Scotland? A 19 years population-based cohort study.
    Gurumurthy M; Lahiri R; Scott N; Miller I; Cruickshank ME; Parkin DE
    Scott Med J; 2013 May; 58(2):88-94. PubMed ID: 23728753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior.
    Bansal N; Herzog TJ; Seshan VE; Schiff PB; Burke WM; Cohen CJ; Wright JD
    Obstet Gynecol; 2008 Jul; 112(1):64-70. PubMed ID: 18591309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FIGO staging for carcinosarcoma: can the revised staging system predict overall survival?
    Pradhan TS; Stevens EE; Ablavsky M; Salame G; Lee YC; Abulafia O
    Gynecol Oncol; 2011 Nov; 123(2):221-4. PubMed ID: 21889193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
    Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS
    Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of care, predictors and outcomes of chemotherapy for uterine carcinosarcoma: a National Cancer Database analysis.
    Rauh-Hain JA; Starbuck KD; Meyer LA; Clemmer J; Schorge JO; Lu KH; Del Carmen MG
    Gynecol Oncol; 2015 Oct; 139(1):84-9. PubMed ID: 26307402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome and natural history of uterine adenosarcomas.
    Arend R; Bagaria M; Lewin SN; Sun X; Deutsch I; Burke WM; Herzog TJ; Wright JD
    Gynecol Oncol; 2010 Nov; 119(2):305-8. PubMed ID: 20688363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic parameters in carcinosarcomas of the uterus: a clinico-pathologic study.
    Bodner-Adler B; Bodner K; Obermair A; Czerwenka K; Petru E; Leodolter S; Mayerhofer K
    Anticancer Res; 2001; 21(4B):3069-74. PubMed ID: 11712812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic determinants in patients with uterine and ovarian carcinosarcoma.
    Rauh-Hain JA; Shoni M; Schorge JO; Goodman A; Horowitz NS; del Carmen MG
    J Reprod Med; 2013; 58(7-8):297-304. PubMed ID: 23947079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of adjuvant radiation therapy on survival in women with uterine carcinosarcoma.
    Clayton Smith D; Kenneth Macdonald O; Gaffney DK
    Radiother Oncol; 2008 Aug; 88(2):227-32. PubMed ID: 18160157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of radiation in improving survival for early-stage carcinosarcoma and leiomyosarcoma.
    Wright JD; Seshan VE; Shah M; Schiff PB; Burke WM; Cohen CJ; Herzog TJ
    Am J Obstet Gynecol; 2008 Nov; 199(5):536.e1-8. PubMed ID: 18511017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis.
    Nemani D; Mitra N; Guo M; Lin L
    Gynecol Oncol; 2008 Oct; 111(1):82-8. PubMed ID: 18674808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival and risk factors associated with uterine sarcomas and carcinosarcomas in stage I and II.
    Visnovsky J; Kudela E; Slavik P; Krkoska M; Buocik P; Szepe P; Danko J
    Neuro Endocrinol Lett; 2015; 36(8):750-7. PubMed ID: 26921575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A population-based series of uterine carcinosarcomas with long-term follow-up.
    Sorbe B; Paulsson G; Andersson S; Steineck G
    Acta Oncol; 2013 May; 52(4):759-66. PubMed ID: 23072724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective analysis of 80 cases with uterine carcinosarcoma, leiomyosarcoma and endometrial stromal sarcoma in China, 1988-2007.
    Gao Y; Meng H; Zhang Y; Jiao T; Hui N
    Int J Clin Exp Pathol; 2014; 7(4):1616-24. PubMed ID: 24817958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian and uterine carcinosarcomas: a comparative analysis of prognostic variables and survival outcomes.
    Garg G; Shah JP; Kumar S; Bryant CS; Munkarah A; Morris RT
    Int J Gynecol Cancer; 2010 Jul; 20(5):888-94. PubMed ID: 20606539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic features of surgical stage I uterine carcinosarcoma.
    Ferguson SE; Tornos C; Hummer A; Barakat RR; Soslow RA
    Am J Surg Pathol; 2007 Nov; 31(11):1653-61. PubMed ID: 18059221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Incidence of Carcinosarcoma among Patients Previously Treated with Tamoxifen.
    Segev Y; Arnon E; Siegler E; Gemer O; Goldberg Y; Auslender R; Kaldawy A; Lavie O
    Isr Med Assoc J; 2017 Mar; 19(3):164-167. PubMed ID: 28457094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Black race independently predicts worse survival in uterine carcinosarcoma.
    Erickson BK; Doo DW; Zhang B; Huh WK; Leath CA
    Gynecol Oncol; 2014 May; 133(2):238-41. PubMed ID: 24613675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for disease-free and overall survival of patients with uterine carcinosarcoma.
    Şükür YE; Taşkın S; Varlı B; Ateş C; Güngör M; Ortaç F
    Int J Clin Oncol; 2018 Feb; 23(1):114-120. PubMed ID: 28836024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.